雷帕霉素对异种单向混合淋巴细胞培养的免疫抑制作用
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Effect of New Immunosuppressant-Rapamycin on One-way Mixed Lymphocyte Culture
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察新型免疫抑制剂雷帕霉素(Rapamycin,RPM)对异种单向混合淋巴细胞培养(one-way XMLC)的免疫抑制作用.方法:①无菌采集小鼠脾淋巴细胞,经丝裂毒素处理,作刺激细胞;②取健康成人外周血淋巴细胞(hPBL),作反应细胞;③异种单向混合淋巴细胞培养;④实验分对照组(不用药)、RPM组,实验组(用药组)又分不同药物浓度组.结果:①小鼠脾淋巴细胞明显刺激人外周血淋巴细胞(hPBL)增殖,3H-TdR掺入值(cpm)显著增高(P<0.05);CD4、CD8、IgG、IgM细胞含量明显升高,有显著差异(P<0.05).②各实验组的cpm值下降,RPM的IC50(50%有效抑制浓度)≈1.5nmol/L.测定各实验组的CD4,CDB,IgG,IgM细胞含量下降,药物的IC5o与上相似.结论:①人→小鼠单向混合淋巴细胞培养,具有明显细胞增殖反应.②RPM对异种单向混合淋巴细胞培养具有明显的免疫抑制效果,其作用呈剂量依赖性.

    Abstract:

    Objective: Observing human to mouse one-way mixed lymphocyte culture(xMIC) and the effect of new immunosuppressant-Rapamycin on XMIC. Methods: Mouse splenic lymphocyte were collected and treated by mitomycin as activating cell; Human Peripheral blood lymphocytes(hPBL)were separated and gathered as reacting cell;Mouse splenic lymphocyte and hPBL wee mixed to incubate for 1 week; The researchers designed control 、RPM groups,and experiment(drugs) grup have different concentration. Results: HPBL in the experiment groups (mixed mouse lymphocyte)proliferated obviously, the amount of3 H-TdR in corporation increased evidently( P < 0.05, The mean percentage of CD4, CD8, LgG, LgM positive cells rose markedly. HPBL in the experiment groups less proliferated, the amount of 3H-TdR incorporation declined,RPM' s ic50 (50% inhibition concentration)approximately in 1.5 nmol/L; the mean percentage of CD4, CD8, IgG, IgM positive cells fell obviously. Conclusion: The human to mouse one-way MLC has obvious lymphocyte proliferation. New immunosuppressants-Rapamycin have powerful effete on XMLC.

    参考文献
    相似文献
    引证文献
引用本文

夏国伟,张元芳,丁强.雷帕霉素对异种单向混合淋巴细胞培养的免疫抑制作用[J].南京医科大学学报(自然科学版),2004,18(6):

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:
通知关闭
郑重声明